![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | (2006.01) |
C07D 471/04 | (2013.01) |
(11) | Number of the document | 3915984 |
(13) | Kind of document | T |
(96) | European patent application number | 20740931.9 |
Date of filing the European patent application | 2020-01-17 | |
(97) | Date of publication of the European application | 2021-12-01 |
(45) | Date of publication and mention of the grant of the patent | 2024-10-30 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2020/072582 |
Date | 2020-01-17 |
(87) | Number | WO 2020/147803 |
Date | 2020-07-23 |
(30) | Number | Date | Country code |
201910057056 | 2019-01-19 | CN | |
202010037085 | 2020-01-14 | CN |
(72) |
SHI, Dongfang , CN
FU, Changjin , CN
GU, Jie , CN
ZHANG, Min , CN
GONG, Weiwei , CN
LI, Pengfei , CN
|
(73) |
Jiangsu Atom Bioscience and
Pharmaceutical Co., Ltd. ,
Suite 401, Building C31, Biomedical Industry Park
218 Xinghu Street, Suzhou Industrial Park
China (Jiangsu) Pilot Free Trade Zone-Suzhou Area, Suzhou City, Jiangsu Province, 215123,
CN
|
(54) | SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |
SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |